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Background: Preeclampsia is associated with fetal growth restriction and low birth
weights. Neurotrophins, which mediate neuronal growth and development, are also
increased in the placenta and cord blood in preeclampsia. Hence, the aim of this study
was to determine whether fetal head growth is altered in preeclampsia, adjusting for
growth restriction and other confounding variables.
Methods: This research included a retrospective cohort study, looking at fetal head
circumference at birth, plus a case–control study examining fetal head circumference
at mid-gestation. The head circumference at birth analysis consisted of 14,607 preg-
nancies (preeclampsia=382, control=14,225), delivered between July 2006 and June
2012 at Nepean Hospital, Australia. Head circumference at birth, in addition to other
maternal and fetal variables, was sourced from the Nepean Obstetric Database. The
head circumference at mid-gestation study consisted of 756 pregnancies (preeclamp-
sia=248, control=508), delivered within the same data collection period at Nepean
Hospital. Head circumference at mid-gestation was retrieved from an earlier ultrasound
scan. Exclusion criteria included >1 fetus, illegal drug use, alcohol consumption, and
chronic or gestational hypertension. Generalized linear models were used to analyze
fetal head circumference in preeclampsia versus controls, adjusting for confounding
variables.
Results: Head circumference increased at a greater rate in preeclampsia versus controls,
adjusted for gestation, fetal gender, birth weight and length, smoking, maternal BMI,
and growth restriction. At mid-gestation, there was no difference in head circumference
between preeclampsia and controls.
Conclusion: For the first time, this research has suggested increased fetal head growth
in preeclampsia, adjusted for confounders. This finding may be explained by altered
fetal exposure to neurotrophins in preeclampsia. The long-term neurodevelopmental
consequences of preeclampsia remain unclear.
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Introduction
Preeclampsia is a leading cause of fetomaternal morbidity and
mortality. The exact etiology of preeclampsia remains unsolved,
though placental dysfunction is central. Specifically, impaired
implantation results in an abnormally shallow placenta, with
potential for vascular insufficiency and subsequent fetal growth
disturbance (1, 2). Additional to low birth weights, preeclamp-
sia is associated with asymmetric growth restriction, whereby
fetal brain growth is maintained at the expense of less critical
organs (3, 4). Accordingly, fetal head growth might be altered in
preeclampsia; however, this has not been well established (5).
More than nutrient supply, brain growth is determined by neu-
rotrophins, including brain-derived neurotrophic factor (BDNF).
As key mediators of neuronal growth, disorders associated with
alterations in BDNF are linked to changes in brain volume
(6, 7). In preeclampsia, placental and cord blood BDNF levels
are also increased (8, 9), with possible consequences for fetal
neurodevelopment.
Head circumference closely relates to brain volume and is
routinely performed on all newborns (10). The aim of this study
was to introduce the concept of altered fetal head growth in
preeclampsia. It was hypothesized that fetal head growth would
be increased in preeclampsia, adjusting for growth restriction and
other confounding variables.
Materials and Methods
This research included a retrospective cohort study examining
fetal head circumference at birth plus a case–control study exam-
ining head circumference at mid-gestation. Singleton pregnancies
delivered at Nepean Hospital, Australia, between July 1, 2006, and
June 30, 2012, were considered eligible. Each included pregnancy
had a single normal fetus. Exclusion criteria were chronic or ges-
tational hypertension, alcohol consumption, and illegal drug use.
Pregnancy information was sourced from the Nepean Obstetric
Database, the information in which is updated and maintained
during and after pregnancy and contributes to state-wide data
collection.
The Ethics Committee of the Sydney West Area Health Service
approved this study according to the Declaration of Helsinki.
Preeclampsia was defined as de novo hypertension (systolic
BP 140mmHg and/or diastolic BP 90mmHg) and
proteinuria (0.3 g/24 h or spot urine protein/creatinine
ratio 30mg/mmol) after 20weeks’ gestation, in accordance
with recommendations proposed by the International Society for
the Study of Hypertension in Pregnancy (11).
In the head circumference at birth analysis (Figure 1A), addi-
tional exclusion criteria were applied; these being, maternal BMI
<10 or >50, gestation at birth <20weeks, and birth weight
<500 g.
The head circumference at mid-gestation analysis (Figure 1B)
followed the same exclusion criteria as the head circumference
at birth analysis, except cutoffs for maternal BMI, gestation,
and birth weight were not applied. Viewpoint software was used
to retrieve fetal morphometry from mid-gestation ultrasound
scans, with pregnancies lacking such data excluded. Remaining
preeclamptic pregnancies were matched (1:2) with control preg-
nancies according to maternal age and parity. Control pregnan-
cies were delivered within the same data collection period and
followed the same exclusion criteria. For each preeclamptic case,
matched controls were the first two pregnancies encountered from
a random list, which also had fetal morphometry data available
from a mid-gestation scan.
Comparisons of maternal and fetal characteristics were per-
formed using GraphPad Prism 6 for Windows (Version 6.01;
GraphPad Software, Inc., La Jolla, CA, USA).
Continuous maternal and fetal characteristics were compared
between groups using Mann–Whitney U test, as the normality
assumption was violated. Categorical characteristics were com-
pared using either Fisher’s exact test or Chi-square test, depending
on group size.
A multivariate generalized linear model (GLM) was used to
model head circumference at birth. Given that mother could be
in the database more than once (if the mother had more than one
child in the study period), this correlation was accounted for in
the model. The effect of preeclampsia was investigated adjusted
for gestational age, fetal gender, birth weight, birth length, and
fetal growth restriction, as well as the mother’s BMI and whether
they smoked during their pregnancy. An interaction between
preeclampsia and gestational agewas also included in themodel to
investigate the rate at which head circumference at birth increased.
Another GLM was used to model head circumference at mid-
gestation. The effect of preeclampsia was adjusted for gestational
age at ultrasound, fetal gender, maternal BMI, and smoking status
during pregnancy.
For all analyzes, a two-sided p-value<0.05 was considered sta-
tistically significant. No corrections have been made for multiple
comparisons. SAS v9.3 (SAS Institute Inc., Cary, NC, USA) was
used for the GLMmodels.
Results
Between July 1, 2006, and June 30, 2012, 22,558 pregnancies
were delivered at Nepean Hospital, 753 of which were diagnosed
with preeclampsia. Following application of the exclusion crite-
ria, 19,358 pregnancies remained eligible: 588 preeclamptics and
18,770 controls. Enforcement of maternal BMI, gestation, and
birth weight cutoffs excluded a further 179 pregnancies. Of the
remaining eligible pregnancies, 4,572 were excluded from the
model due to missing data, mostly owing to blank data entry for
fetal growth restriction and/or maternal BMI. The head circum-
ference at birth GLM therefore consisted of 14,607 pregnancies:
382 preeclamptics and 14,225 controls.
The head circumference at mid-gestation analysis commenced
with the same 588 preeclamptics which remained following appli-
cation of the exclusion criteria. Of these, 318 preeclamptics were
ineligible because they lacked fetalmorphometry data fromamid-
gestation scan. The remaining 270 preeclamptics were matched
(1:2) with 540 controls, which also contained fetal morphometry
data from a mid-gestation scan. Due to missing data, especially
maternal BMI, 54 pregnancies were finally excluded. The GLM
for head circumference at mid-gestation thus consisted of 756
pregnancies: 248 preeclamptics and 508 controls.
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FIGURE 1 | Flow of pregnancies for inclusion. (A) Head circumference at birth population. (B) Head circumference at mid-gestation population.
In the head circumference at birth population, preeclampsia
was associated with an earlier gestation at delivery, increased
maternal BMI, nulliparity and smoking, plus decreased birth
weight, child length, and head circumference parameters
(Table 1).
At mid-gestation, the preeclampsia group also demonstrated
increased maternal BMI and smoking; however, fetal morphome-
try was comparable.
The GLM for head circumference at birth, which included an
interaction between preeclampsia and gestational age, revealed
a significantly increased slope in the preeclampsia group versus
controls over the gestational ages modeled (Figure 2; interac-
tion p-value<0.001). The lines are shown to cross at 36.3 weeks
gestation. Before this time, a delivered preeclamptic fetus is esti-
mated to have a smaller fetal head circumference than a control
fetus (adjusting for confounders), and the difference between
the two fetuses becomes smaller as gestational age increases.
Conversely, a preeclamptic fetus born after 36.3 weeks gestation
is estimated to have a larger head circumference than a con-
trol fetus, and this difference increases with increasing gesta-
tional age. Table 2 illustrates a comparison of head circumference
adjustedmeans, for that average baby inFigure 2, at representative
gestations.
Head circumference at mid-gestation was comparable between
preeclampsia and control groups, adjusting for gestation at
ultrasound, maternal BMI, smoking, and fetal gender [estimated
mean difference (95% CI)= 0.003 higher in preeclampics ( 0.08
to 0.09); p= 0.94].
Discussion
For the first time, this study has suggested fetal head circum-
ference to increase at a greater rate in preeclampsia, adjust-
ing for growth restriction and other confounding variables. At
mid-gestation, fetal head circumference was comparable between
preeclampsia and control groups.
A major strength of this study is large sample size; however,
numerical errors made during data entry became a concern. To
address this issue, cutoff criteria for maternal BMI, gestation, and
birth weight were applied, the aim being to eliminate incorrect
data. The application of cutoffs is unlikely to have introduced sig-
nificant bias, however, since broad limits were used and relatively
few pregnancies were excluded. Indeed, most excluded pregnan-
cies were due to missing data, especially maternal BMI. Since the
head circumference at birth model consisted of one measurement
for each fetus, caution should be observed in interpreting head cir-
cumference changes as changes in velocity. Nonetheless, repeated
measures are not feasible on a large sample size and despite its
limitations, cross-sectional birth data are generally accepted as the
best method of generating growth curves (12). Finally, extension
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TABLE 1 |Maternal and fetal characteristics.
Characteristic Head circumference at birth population Head circumference at mid-gestation population
Preeclampsia (382) Control (14,225) p-value Preeclampsia (248) Control (508) p-value
Maternal age (yr) 28.0 (23.0–33.0) 28.0 (24.0–32.0) 0.12 28.0 (23.3–33.0) 28.0 (23.3–33.0) 0.76a
Maternal BMI (kg/m2) 28.1 (23.7–34.6) 24.5 (21.4–29.4) <0.001 27.9 (23.8–34.8) 24.2 (21.2–29.1) <0.001
Nulliparous 45.5% 25.5% <0.001c 60.5% 59.4% 0.81a,b
Smoking 12.0% 20.9% <0.001c 8.1% 17.3% <0.001b
Male fetus 53.1% 51.4% 0.55c 54.0% 51.8% 0.59b
Fetal growth restriction 13.1% 2.4% <0.001c 11.6% 1.3% <0.001b
Fetal morphometry at birth
Gestation at delivery (wk) 38.1 (36.0–39.3) 39.7 (38.9–40.7) <0.001 38.1 (36.2–39.2) 39.6 (39.0–40.5) <0.001
Birth weight (g) 3,100 (2,512–3,546) 3,465 (3,140–3,785) <0.001 3,183 (2,556–3,609) 3,460 (3,115–3,730) <0.001
Child length (cm); N 49.0 (46.0–52.0) 51.0 (49.0–53.0) <0.001 50.0 (47.0–52.0); 240 51.0 (49.0–53.0); 502 <0.001
Head circumference (cm); N 34.0 (32.4–35.3) 34.5 (33.5–35.5) <0.001 34.5 (32.8–35.5); 241 34.5 (33.5–35.5); 502 0.02
Fetal morphometry at mid-gestation
Gestation at ultrasound 19.1 (18.7–19.6) 19.2 (18.9–19.6) 0.31
Head circumference (mm) 161.5 (156.4–168.4) 162.3 (156.8–169.0) 0.37
Biparietal diameter (mm) 43.6 (42.0–45.8) 43.9 (41.8–45.7) 0.89
Abdominal circumference (mm) 141.6 (135.5–148.4) 143.2 (135.8–150.3) 0.22
Femur length (mm) 29.5 (28.0–31.5) 29.9 (28.3–31.5) 0.26
aMatched variables.
bFisher’s exact test.
cChi-square test; continuous data analyzed using Mann–Whitney U test and expressed as median (Q1–Q3).
FIGURE 2 | Adjusted means for fetal head circumference at birth for preeclampics and controls over gestational ages. Head circumference increased
faster in preeclampsia versus controls (interaction p-value<0.001). This comparison assumed a male baby of average birth weight and length, with growth
restriction, average maternal BMI, and a non-smoking mother. Preeclampsia ( ); control ( ).
should not be made outside the gestational ages modeled here in
this article.
The purpose of this researchwas to introduce the novel concept
of altered fetal head growth in preeclampsia. As mid-gestation
head circumference measures were comparable in this study, and
birth head circumference measures indicated an increased head
growth in preeclampsia, altered neurodevelopmentmight be a late
event. However, the gestation at birth ranges in this study was
relatively narrow and different between groups. Hence, further
research is required to establish fetal head growth in preeclampsia
versus healthy pregnancy, which might include serial measures of
head circumference in utero.
Similar to previous reports, male gender and increased mater-
nal BMI were associated with larger head circumference at
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TABLE 2 | Comparison of adjusted mean fetal head circumference.
Gestation (wk) Head circumference (cm)
Preeclampsia Control
24 30.2 32.7
28 31.6 33.3
32 33.0 33.9
36 34.4 34.4
40 35.8 35.0
Adjusted for fetal gender, birth weight, birth length, fetal growth restriction, maternal BMI,
and smoking.
birth in this study (12). Birth weight was also smaller in
preeclamptic fetuses, again consistent with earlier findings (5,
13). However, there are few published studies on head growth in
preeclampsia and none adjusted for confounding variables (14).
Comparison of our results with previous findings is therefore
restricted.
Preeclampsia is associated with altered fetal growth patterns. In
particular, it is linked to small for gestational age (SGA) fetuses;
a finding frequently explained by decreased placental perfusion
(2, 5, 13). In chronic placental insufficiency, head growth may be
spared at the expense of less critical tissues, resulting in asym-
metric growth restriction. However, this study observed relatively
increased head growth in preeclampsia, adjusting for growth
restriction. An alternative mechanism may therefore explain our
findings.
Altered head growth in preeclampsia may be explained by
increased fetal exposure to neurotrophins, including BDNF. An
essential regulator of normal neurodevelopment, disorders linked
to alterations in BDNF demonstrate changes in brain growth (6, 7,
15). In term preeclampsia, elevated BDNF is also observed in both
the placenta and the cord blood (8, 9). Accordingly, increased fetal
exposure to BDNF at term may explain increased head growth in
preeclampsia, although further studies are needed.
In conclusion, for the first time, this study has suggested fetal
head growth to be increased in preeclampsia, adjusted for con-
founding variables. Further investigation is required, and if these
findings are confirmed, the long-term neurodevelopmental con-
sequences of preeclampsia will be the subject of future research
efforts.
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